BMRN icon

BioMarin Pharmaceuticals

553 hedge funds and large institutions have $15.5B invested in BioMarin Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 196 increasing their positions, 191 reducing their positions, and 59 closing their positions.

Holders
553
Holders Change
+5
Holders Change %
+0.91%
% of All Funds
8.72%
Holding in Top 10
11
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.17%
New
67
Increased
196
Reduced
191
Closed
59
Calls
$148M
Puts
$158M
Net Calls
-$9.91M
Net Calls Change
-$124M
Name Market Value Shares Shares
Change
Shares
Change %
SFG
601
Steward Financial Group
Texas
-74 Closed
CT
602
Colonial Trust
South Carolina
-57 Closed
SC
603
Schubert & Co
Texas
-57 Closed
WTC
604
WhitTier Trust Company
Nevada
-29 Closed
TAIM
605
TD Ameritrade Investment Management
Nebraska
-22 Closed
SSC
606
Syverson Strege & Co
Iowa
-16 Closed
AAS
607
Ameritas Advisory Services
Nebraska
-13 Closed
TWC
608
TD Waterhouse Canada
Ontario, Canada
-10 Closed
CSWM
609
Cassady Schiller Wealth Management
Ohio
-5 Closed
CFB
610
Cullen/Frost Bankers
Texas
-4 Closed
Twin Tree Management
611
Twin Tree Management
Texas
JGC
612
J. Goldman & Co
New York
Nomura Holdings
613
Nomura Holdings
Japan
IMC Chicago
614
IMC Chicago
Illinois
HT
615
HAP Trading
New York
CCM
616
CAAS Capital Management
New York
CAC
617
Cowen and Company
New York
PCM
618
Penserra Capital Management
California
$0 10
MCM
619
Masters Capital Management
Georgia
SA
620
SpiderRock Advisors
Delaware
ACM
621
Advent Capital Management
New York
Parallax Volatility Advisers
622
Parallax Volatility Advisers
California
AW
623
Avion Wealth
Texas
$0 10 +10 New